Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Kiniksa Pharmaceuticals International, plc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 96
- −7 vs. Q4 2021
- Shares held
- 30.8M
- +1.35M (+4.6%) vs. Q4 2021
- Total value
- $306.0M
- −$40.4M (−11.7%) vs. Q4 2021
- New holders
- 13
- 36 more added
- Sold out
- 20
- 30 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KNSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $2.99B |
| Q1 2026 | 228 | $2.18B |
| Q4 2025 | 224 | $1.77B |
| Q3 2025 | 204 | $1.59B |
| Q2 2025 | 189 | $1.10B |
| Q1 2025 | 176 | $889.4M |
| Q4 2024 | 160 | $773.1M |
| Q3 2024 | 176 | $991.2M |
| Q2 2024 | 133 | $659.4M |
| Q1 2024 | 154 | $768.1M |
| Q4 2023 | 142 | $600.4M |
| Q3 2023 | 134 | $605.8M |
| Q2 2023 | 127 | $447.7M |
| Q1 2023 | 132 | $339.6M |
| Q4 2022 | 125 | $450.0M |
| Q3 2022 | 104 | $383.2M |
| Q2 2022 | 92 | $290.5M |
| Q1 2022 | 96 | $306.0M |
| Q4 2021 | 103 | $346.4M |
| Q3 2021 | 101 | $332.0M |
| Q2 2021 | 102 | $402.0M |
| Q1 2021 | 105 | $537.6M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Kiniksa Pharmaceuticals International, plc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −25,900−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −24,336−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,157−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −16,157−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −12,317−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,143−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −10,740−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −7,622−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −4,800−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,052−100.0% | Sold out |
| Cornerstone Advisory, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −151−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Amplius Wealth Advisors, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |